Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health
Research output: Contribution to journal › Journal article › Research › peer-review
A number of reports have highlighted problems of conducting publicly funded trials in Europe as a consequence of the European Union (EU) Clinical Trials Directive. The impact of the EU Directive on multi-national trials, which include sites in Europe that are funded by the US National Institutes of Health (NIH) have not been described.
| Original language | English |
|---|---|
| Journal | Clinical Trials |
| Volume | 7 |
| Issue number | 6 |
| Pages (from-to) | 705-18 |
| Number of pages | 14 |
| ISSN | 1740-7745 |
| DOIs | |
| Publication status | Published - 1 Dec 2010 |
- Anti-HIV Agents, Clinical Protocols, Clinical Trials as Topic, Drug and Narcotic Control, Europe, European Union, Government Regulation, Guideline Adherence, Guidelines as Topic, HIV Infections, Humans, Internationality, Multicenter Studies as Topic, National Institutes of Health (U.S.), United States
Research areas
ID: 34171932